FY2026 · period end Mar '26 · from the 10-K filed May 21, 2026
| Metric | FY26Mar '26 | FY25Mar '25 | FY24Mar '24 | FY23Mar '23 | FY22Mar '22 |
|---|---|---|---|---|---|
| Revenue | $0.32B | $0.28B | $0.24B | $0.20B | $0.16B |
| Gross Profit | $0.20B | $0.17B | $0.14B | $0.12B | $0.10B |
| Operating Income | $0.04B | $0.02B | $0.02B | $0.01B | $0.01B |
| Net Income | $0.04B | $0.02B | $0.09B | $0.01B | $0.01B |
| EPS (Diluted) | $1.37 | $0.82 | $3.17 | $0.49 | $0.18 |
| Metric | FY26Mar '26 | FY25Mar '25 | FY24Mar '24 | FY23Mar '23 | FY22Mar '22 |
|---|---|---|---|---|---|
| Total Assets | $0.48B | $0.43B | $0.35B | $0.24B | $0.21B |
| Total Liabilities | — | — | — | — | — |
| Stockholders' Equity | $0.33B | $0.27B | $0.24B | $0.11B | $0.10B |
| Cash & Equivalents | $0.12B | $0.07B | $0.14B | $0.11B | $0.10B |
| Total Debt | — | — | — | — | — |
| Metric | FY26Mar '26 | FY25Mar '25 | FY24Mar '24 | FY23Mar '23 | FY22Mar '22 |
|---|---|---|---|---|---|
| Operating Cash Flow | $0.07B | $0.06B | $0.05B | $0.03B | $0.03B |
| Capital Expenditures | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — |
| Metric | FY26Mar '26 | FY25Mar '25 | FY24Mar '24 | FY23Mar '23 | FY22Mar '22 |
|---|---|---|---|---|---|
| Gross Margin | 62.6% | 62.4% | 60.7% | 61.0% | 62.4% |
| Operating Margin | 0.1% | 0.1% | 0.1% | 0.1% | 0.0% |
| Net Margin | 0.1% | 0.1% | 0.4% | 0.1% | 0.0% |
| Return on Equity | 13.1% | 9.2% | 49.9% | 14.1% | 7.3% |
| Return on Assets | 8.5% | 5.9% | 29.0% | 6.4% | 3.2% |
| Debt / Equity | — | 0.09× | — | — | — |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001193125-26-318055 | Jul 27, 2026 | Jul 27, 2026 | Jul 27, 2026 20:05 UTC | EDGAR |
| 10-Q | 0001193125-26-318081 | Jun 30, 2026 | Jul 27, 2026 | Jul 27, 2026 20:11 UTC | EDGAR |
| 8-K | 0001193125-26-276749 | Jun 22, 2026 | Jun 22, 2026 | Jun 22, 2026 12:30 UTC | EDGAR |
| 8-K | 0001193125-26-254661 | Jun 3, 2026 | Jun 3, 2026 | Jun 3, 2026 12:30 UTC | EDGAR |
| 10-K | 0001193125-26-234423 | Mar 31, 2026 | May 21, 2026 | May 21, 2026 20:11 UTC | EDGAR |
| 8-K | 0001193125-26-228898 | May 18, 2026 | May 18, 2026 | May 18, 2026 20:05 UTC | EDGAR |
| 8-K | 0001193125-26-032780 | Feb 2, 2026 | Feb 2, 2026 | Feb 2, 2026 13:30 UTC | EDGAR |
| 8-K | 0001193125-26-022562 | Jan 26, 2026 | Jan 26, 2026 | Jan 26, 2026 21:05 UTC | EDGAR |
Direct links to SEC EDGAR. AGYS has additional filings available on the SEC site.
6 numbers AGILYSYS INC later changed — same XBRL tag, both filings linked.
Operating Income (Loss)·FY 2013
Major restatementwas-$1.1M
Revised down in a 10-K/A.
Net Cash Provided by (Used in) Operating Activities·Q2 2011
Major restatementwas-$5.1M
Revised down in a 10-Q.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·FY 2013
Major restatementwas-$1.6M
Revised down in a 10-K/A.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·Q2 2012
Major restatementwas-$392K
Revised down in a 10-Q.
Operating Income (Loss)·Q2 2012
Major restatementwas-$539K
Revised down in a 10-Q.
Net Cash Provided by (Used in) Operating Activities·Q3 2011
Major restatementwas-$9.8M
Revised down in a 10-Q.
AGYS is not the only one.
See every restatement we've found across the market — or get an alert the next time AGYS revises a number.
Restatements are detected by comparing every vintage of a fact across all of AGILYSYS INC's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows AGYS's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling AGILYSYS INC — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on AGYS yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on AGYS and publish the result to your public profile.
Ask about AGILYSYS INC
Continue in Workspace — cited answers on AGYS, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs